Patient preferences in severe COPD and asthma: a comprehensive literature review
Authors Bereza B, Nielsen A, Valgardsson S, Hemels M, Einarson T
Received 4 February 2015
Accepted for publication 6 March 2015
Published 8 April 2015 Volume 2015:10(1) Pages 739—744
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Richard Russell
Basil G Bereza,1 Anders Troelsgaard Nielsen,2 Sverrir Valgardsson,3 Michiel EH Hemels,2 Thomas R Einarson1
1Leslie Dan Faculty of Pharmacy, University of Toronto, ON, Canada; 2Janssen A/S, Birkerød, Denmark; 3Janssen-Cilag A/S, Oslo, Norway
Background: Management of chronic incurable diseases such as chronic obstructive pulmonary disease (COPD) and asthma is difficult. Incorporation of patient preferences is widely encouraged.
Purpose: To summarize original research articles determining patient preference in moderate-to-severe disease.
Methods: Acceptable articles consisted of original research determining preferences for any aspect of care in patients with COPD/asthma. The target population included those with severe disease; however, articles were accepted if they separated outcomes by severity or if the majority had at least moderate-to-severe disease. We also accepted simulation research based on scenarios describing situations involving moderate-to-severe disease that elicited preferences. Two reviewers searched Medline and Embase for articles published from the date of inception of the databases until the end of November 2014, with differences resolved through consensus discussion. Data were tabulated and analyzed descriptively.
Results: About 478 articles identified, 448 were rejected and 30 analyzed. There were 25 on COPD and five on asthma. Themes identified as most important in COPD were symptom relief (dyspnea/breathlessness), a positive patient–physician relationship, quality-of-life impairments, and information availability. Patients strongly preferred sponsors’ inhalers. At end-of-life, 69% preferred receiving CPR, 70% wanted noninvasive, and 58% invasive mechanical intervention. While patients with asthma preferred treatments that increased symptom-free days, they were willing to trade days without symptoms for a reduction in adverse events and greater convenience. Asthma patients were willing to pay for waking up once and not needing their inhaler over waking up once overnight and needing their inhaler.
Conclusion: Few studies have examined patient preference in these diseases. More research is needed to fill in knowledge gaps.
Keywords: autonomy, end-of-life care, convenience, satisfaction, willingness-to-pay
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]